ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.630,44
0,41%
S&P 500
5.487,03
0,25%
US Dollar vs BRL
5,4413
0,00%
Bitcoin
65.578,82
0,68%
Brent Oil
84,455
-0,39%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. AMEX
  6. Dor Biopharma (DOR)

  7. Dor Biopharma (DOR) Notícias

DOR

Dor (DOR)

Dor Biopharma
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:AMEX:DOR
DataHoraFonteTítuloCódigoCompanhia
07/04/200610:19Business WireDOR BioPharma Announces Advances in Mucosal Vaccines for Botulinum Toxin; Antigens are Made Using Dowpharma's Pfenex ExpressionAMEX:DORDor Biopharma
06/04/200616:28Business WireDOR BioPharma Announces Private Equity Financing of $3.65 Million with Institutional InvestorsAMEX:DORDor Biopharma
30/03/200611:00Business WireDOR BioPharma Reports Year End 2005 Financial Results and Accomplishments; DOR Provides Guidance on Regulatory Filings on orBecAMEX:DORDor Biopharma
08/02/200612:25Business WireDOR BioPharma Provides Financial Guidance and Update on European Regulatory Plans for orBec(R)AMEX:DORDor Biopharma
30/01/200620:48Business WireDOR BioPharma Announces Positive Phase I Results of RiVax(TM), its Vaccine Against Ricin Toxin; Vaccine is Immunogenic and WellAMEX:DORDor Biopharma
25/01/200613:31Business WireDOR BioPharma Achieves Manufacturing Milestone in Development of RiVax(TM); DOR and Its Collaborators Achieve 2nd Milestone AheaAMEX:DORDor Biopharma
20/01/200611:10Business WireDOR BioPharma Reports Positive New Survival Findings from Previously Completed Phase II and III Clinical Trials of orBec(R); ResAMEX:DORDor Biopharma
19/01/200612:26Business WireDOR BioPharma Secures $6 Million Equity Commitment from Fusion CapitalAMEX:DORDor Biopharma
15/11/200512:04Business WireDOR BioPharma Plans FDA NDA and European MAA Filing Strategy for orBecAMEX:DORDor Biopharma
14/11/200519:26Business WireDOR BioPharma Inc. Reports Third Quarter 2005 Financial Results and Reviews Recent Achievements; Conference Call Scheduled for NAMEX:DORDor Biopharma
07/11/200510:00Business WireDOR BioPharma to Present at the Rodman & Renshaw Techvest 7th Annual Healthcare ConferenceAMEX:DORDor Biopharma
02/11/200509:00Business WireDOR BioPharma Executes Letter of Intent for Acquisition of Gastrotech Pharma; Acquisition Bolsters Biotherapeutics PipelineAMEX:DORDor Biopharma
01/11/200519:34Business WireDOR BioPharma Receives Notice of Delisting from American Stock Exchange; Company to Continue to Negotiate Potential Compliance-AAMEX:DORDor Biopharma
14/10/200510:17Business WireDOR BioPharma Provides Update on Programs and Corporate MattersAMEX:DORDor Biopharma
15/09/200518:41PR Newswire (US)Dr. Chris Dale, Vice President, Technology, Cambrex Biopharmaceuticals and Dr. Robert N. Brey, Chief Scientific Officer, DOR BioAMEX:DORDor Biopharma
26/07/200514:07PR Newswire (US)DOR BioPharma and Dowpharma Enter Into a Joint Development Agreement for BT-VACC(TM), DOR's Oral Vaccine Against Botulinum ToxinAMEX:DORDor Biopharma
15/06/200507:30Business WireDOR BioPharma, Inc. Announces Positive Interim Results from Phase I Clinical Trial of RiVax, Its Ricin Toxin VaccineAMEX:DORDor Biopharma
13/06/200512:14Business WireDOR BioPharma to Present at the Rodman & Renshaw Techvest 2nd Annual Security and Connectivity ConferenceAMEX:DORDor Biopharma
04/05/200511:51Business WireDOR BioPharma to Present at the Rodman & Renshaw Techvest 2nd Annual Global Healthcare ConferenceAMEX:DORDor Biopharma
04/05/200509:30Business WireDOR BioPharma Appoints T. Jerome Madison to Board of DirectorsAMEX:DORDor Biopharma
07/01/200511:30PR Newswire (US)DOR BioPharma and Cambrex Enter into a Development and Manufacturing Process Agreement for RiVax(TM)AMEX:DORDor Biopharma
 Apresentando as notícias mais relevantes sobre:AMEX:DOR

Seu Histórico Recente

NASDAQ
FFIE
Faraday Future Intellige...
NYSE
NEE.PRP
NextEra Energy, Inc.
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados